oral semaglutide approval In Brief: Rybelsus R2 Rebranded as Ozempic Oral GLP-1 Wegovy chases approval

We need to do more research to find ways to help manage weight gain and reduce risks during pregnancy when stopping GLP-1 medications. Authorship: In addition to Maya and Powe, Mass General Brigham authors include Deepti Pant, Yiran Fu, Kaitlyn James, Carolina Batlle, Sarah Hsu, Diana C

A 5-day interval is within safe parameters (above 72 hours)

Additional co-authors on the Nature Communications study include: Alina P

Priming microglia for innate immune memory in the brain

The best maintenance strategy usually combines medical follow-up, protein-focused nutrition, resistance training, hydration, sleep support, appetite monitoring, lab review, and a realistic long-term medication plan when appropriate